Haikou Mingheng Biotechnology
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Haikou Mingheng Biotechnology between 18 Sep 2025 and 7 Jan 2026. Test scores average over 4, no score below 3, and at least 2 tests warrant a tentative Finnrick Rating of D (Poor).
Finnrick Rating™
Tentative Rating
Haikou Mingheng Biotechnology
Retatrutide
Tested 4 Samples
Last test 7 Jan 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Haikou Mingheng Biotechnology
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
7 Jan 2026
First
18 Sep 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 7 Jan 2026 | View | 15mg | 15.3mg | +2.0% | 99.60% | (no batch ID) | White Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 18 Nov 2025 | View | 5mg | 5.65mg | +13.0% | 98.90% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 6 Nov 2025 | View | 10mg | 9.59mg | -4.1% | 99.56% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 18 Sep 2025 | View | 30mg | 28.9mg | -3.7% | 99.95% | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab E | Public | |